Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS) (Q58750007)
Jump to navigation
Jump to search
scientific article published on 11 September 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS) |
scientific article published on 11 September 2018 |
Statements
Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS) (English)
Shinichiro Yamada
Atsushi Hashizume
Daisuke Ito
Fumie Kinoshita
Yumiko Kobayashi
Akihiro Hirakawa
Tomohiko Nakamura
11 September 2018
1 reference
1 reference
1 reference